Browse by author
Lookup NU author(s): Dr Sam Tingle, Dr Avinash Sewpaul, Lucy BatesORCiD, Dr Emily ThompsonORCiD, Victoria Shuttleworth, Rodrigo Figueiredo, Dr Ibra Al-Naseri, Professor Simi AliORCiD, Colin Wilson, Professor Neil SheerinORCiD
This is the authors' accepted manuscript of an article that has been published in its final definitive form by Lippincott Williams & Wilkins, 2020.
For re-use rights please refer to the publisher's terms and conditions.
Background: MicroRNAs (miRNA) are short non-coding RNAs which each cause repression of many target genes. Previous work has demonstrated that therapeutic blockade of single microRNAs is possible. miR-24-3p and miR-145-5p are reported to have a detrimental role in ischaemia reperfusion injury (IRI). As the action of miRNAs is inhibitory, we hypothesised that dual blockade of both miRNAs could synergistically upregulate shared target genes.Methods: Quantification of miRNA expression in donated kidneys was performed using PCR panels. IRI was modelled in vitro by placing Human Umbilical Vein Endothelial Cells (HUVECs) into a hypoxic incubator (1% O2) for 24hrs, with reoxygenation for 6hrs. RNA expression was quantified with RT-qPCR and protein expression assessed with Western blot. Antisense oligonucleotides (ASOs) were used to inhibit miRNAs.Results: miR-24-3p and miR-145-5p were highly expressed in human kidneys following extended cold ischemia. In vitro, hypoxia caused significant upregulation of miR-24-3p (p≤0.001) and miR-145-5p (p≤0.001), and significant downregulation in mRNA of shared targets SOD2 (p≤0.001) and HMOX1 (p≤0.001). These changes were mirrored at the protein level. Dual inhibition of both miR-24-3p and miR-145-5p prior to hypoxia-reoxygenation caused significant upregulation of SOD2 and HMOX1 protein; fold-change of 3.17 (p≤0.05) and 6.97 (p≤0.05) respectively. Dual inhibition resulted in reduced cellular ROS production compared to negative control (p≤0.05) and single blockade of miR-24-3p (p≤0.01) or miR-145-5p (p≤0.05).Conclusion: Dual blockade of two miRNAs can act synergistically to increase the expression of shared gene targets. Dual blockade of miR-24-3p and miR-145-5p represents a novel therapeutic option worthy of further research.
Author(s): Tingle SJ, Sewpaul A, Bates L, Thompson ER, Shuttleworth V, Figueiredo R, Ibrahim IK, Ali S, Wilson C, Sheerin NS
Publication type: Article
Publication status: Published
Journal: Transplantation
Year: 2020
Volume: 104
Issue: 9
Pages: 1853-1861
Print publication date: 01/09/2020
Online publication date: 02/03/2020
Acceptance date: 04/02/2020
Date deposited: 15/02/2020
ISSN (print): 0041-1337
ISSN (electronic): 1534-6080
Publisher: Lippincott Williams & Wilkins
URL: https://doi.org/10.1097/TP.0000000000003215
DOI: 10.1097/TP.0000000000003215
Altmetrics provided by Altmetric
